The acidity of Antarctica’s coastal waters could double by the end of the century, threatening whales, penguins and hundreds of other species that inhabit the Southern Ocean, according to new CU Boulder research. Scientists projected that by 2100, the …
The combined effects of acidification and acute warming on the embryos of Pacific herring (Clupea pallasii) Published 26 January 2024 Science Leave a Comment Tags: biological response, fish, laboratory, mortality, multiple factors, North Pacific, …
Season influences interspecific responses of canopy-forming kelps to future warming and acidification at high latitude Published 26 January 2024 Science Leave a Comment Tags: algae, biological response, growth, laboratory, morphology, multiple factors, …
Evaluating the ability of macroalgae to create a chemical refuge for bivalves under ocean acidification conditions in closed-environment experiments Published 26 January 2024 Science Leave a Comment Tags: chemistry, laboratory, mitigation, South Pacific …
For Immediate Release: January 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA announced a new website listing regulations for the Foods Program it plans to …
The FDA Compounding Quality Center of Excellence offers instructor-led trainings, in-person or virtually, to outsourcing facilities with limited space for pharmacy compounders and regulators. These multi-day trainings provide continuing education (CE) …
The FDA Compounding Quality Center of Excellence provides training anytime, anywhere at no cost. Each course provides continuing education (CE) credits for pharmacists, pharmacy technicians, physicians and nurses. Training Description CE Credits Airflow …
The FDA Compounding Quality Center of Excellence annual conference is open to outsourcing facilities, compounders interested in becoming outsourcing facilities, regulators and other stakeholders. Attendees engage with FDA and learn about emerging trends …
The FDA Compounding Quality Center of Excellence conducts the Compounding Outsourcing Facilities Annual Study to better understand industry perspectives and challenges, as well as dynamics between suppliers and purchasers. Each study includes: a survey of …
FDA established a forum for outsourcing facilities and related stakeholders to discuss issues that affect outsourcing facilities, health care providers that purchase their products and associated stakeholders as part of FDA’s Compounding Quality Center of …
The FDA Compounding Quality Center of Excellence offers free recorded webinars to provide information about current good manufacturing practice standards and the agency’s inspectional processes. Topic Description Cleanrooms and Cleanroom Behaviors: Why …
Complex generic products are typically harder to develop, which means that many complex products face less competition than other products, and therefore can be more expensive and less accessible to the patients who need them. The initiatives below are …
The third component of the Drug Competition Action Plan is aimed at reducing the so-called “gaming” that frustrates and delays generic drug approvals and extends brand monopolies beyond what Congress intended with the Hatch-Waxman Amendments of 1984. Such …
By clarifying FDA’s regulatory expectations for new entrants and experienced drug developers alike, FDA is supporting prospective generic drug developers and improving the overall quality of ANDAs submitted to the Agency for approval. At the same time, FDA …
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against ChargePoint Holdings Inc. (“ChargePoint” or the “Company …
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Future FinTech Group Inc. (NASDAQ: FTFT …
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of EHang Holdings Limited (NASDAQ: EH), …
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against agilon health, inc. (NYSE: AGL), DocGo, Inc. (NASDAQ: DCGO), and Endeavour Mining …
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kenvue Inc. (NYSE: KVUE) on behalf of long-term stockholders following a class …
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against GrafTech International Ltd. (“GrafTech” or the “Company”) (NYSE: …
